CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale President sold 48,213 shares at $33.93 ($1,635,867)
- 144/A Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 41,150 shares at $33.93 ($1,396,220)
- 4 Open-market sale Chief Executive Officer sold 94,035 shares at $33.93 ($3,190,608)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 784 shares (grant or award)
- 4 Grant or award Director acquired 760 shares (grant or award)
- 4 Grant or award Director acquired 1,212 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4/A Open-market sale Chief Financial Officer sold 1,816 shares at $31.20 ($56,659)
- 4/A Open-market sale Chief Executive Officer sold 7,625 shares at $31.21 ($237,976)
- 4/A Open-market sale President sold 2,109 shares at $31.20 ($65,801)
- 4 Open-market sale Chief Executive Officer sold 7,625 shares at $31.21 ($237,976)
- 4 Open-market sale President sold 2,109 shares at $31.20 ($65,801)
- 4 Open-market sale Chief Financial Officer sold 1,816 shares at $31.20 ($56,659)
Page 8 of 14 · 267 filings